Latest News and Press Releases
Want to stay updated on the latest news?
-
Former CFO of Alvarion brings decades of experience to Board CAMBRIDGE, Mass., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Anchiano Therapeutics Ltd. (TASE: ANCN), a clinical-stage biopharmaceutical company...
-
CAMBRIDGE, Mass., Aug. 27, 2018 (GLOBE NEWSWIRE) -- BioCanCell Ltd. (TASE: ANCN), a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat...
-
CAMBRIDGE, Mass., Aug. 22, 2018 (GLOBE NEWSWIRE) -- BioCanCell Ltd. (TASE: ANCN), a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat...
-
CAMBRIDGE, Mass., July 03, 2018 (GLOBE NEWSWIRE) -- BioCanCell Ltd. (TASE:BICL), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel...
-
Presented final data from its Phase 2 study of BC-819 for early stage bladder cancer at the 2018 ASCO Genitourinary Cancers Symposium Announced two key hires in clinical development and clinical...
-
Financing, led by Shavit Capital, includes U.S. and Israeli investors CAMBRIDGE, Mass., April 13, 2018 (GLOBE NEWSWIRE) -- BioCanCell Ltd. (TASE:BICL), a clinical-stage biopharmaceutical company...
-
Ronald Knickerbocker, Ph.D. named Senior Vice President of Clinical Development and Data Sciences Sean Daly named Vice President of Clinical Operations CAMBRIDGE, Mass., March 07, 2018 (GLOBE...
-
BC-819 demonstrates meaningful activity Two registrational studies planned to be initiated in 2018 CAMBRIDGE, Mass., Feb. 09, 2018 (GLOBE NEWSWIRE) -- BioCanCell Ltd. (TASE:BICL), a...